USANA Health Sciences (NYSE:USNA) Price Target Cut to $46.00 by Analysts at DA Davidson

USANA Health Sciences (NYSE:USNA) had its target price dropped by research analysts at DA Davidson from $48.00 to $46.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. DA Davidson’s price objective suggests a potential upside of 2.70% from the company’s previous close.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 12th.

USANA Health Sciences Stock Performance

USANA Health Sciences stock traded up $0.18 during mid-day trading on Tuesday, reaching $44.79. The company’s stock had a trading volume of 8,841 shares, compared to its average volume of 80,857. USANA Health Sciences has a 12-month low of $41.45 and a 12-month high of $69.60. The company has a market capitalization of $859.97 million, a P/E ratio of 13.98, a PEG ratio of 1.38 and a beta of 0.94. The firm’s fifty day moving average price is $46.54 and its two-hundred day moving average price is $48.15.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.35. The business had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. On average, research analysts predict that USANA Health Sciences will post 2.75 EPS for the current fiscal year.

Insider Transactions at USANA Health Sciences

In other news, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction on Friday, March 8th. The shares were sold at an average price of $49.05, for a total transaction of $257,022.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total transaction of $178,707.74. The disclosure for this sale can be found here. Over the last three months, insiders have sold 28,598 shares of company stock valued at $1,379,499. Insiders own 0.33% of the company’s stock.

Institutional Trading of USANA Health Sciences

Several institutional investors and hedge funds have recently modified their holdings of the company. Quest Partners LLC purchased a new stake in USANA Health Sciences in the 4th quarter valued at about $66,000. CWM LLC increased its stake in USANA Health Sciences by 49.6% during the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after purchasing an additional 420 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in USANA Health Sciences by 60.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after purchasing an additional 1,274 shares in the last quarter. Trexquant Investment LP acquired a new position in USANA Health Sciences during the 4th quarter valued at approximately $266,000. Finally, Teacher Retirement System of Texas acquired a new position in USANA Health Sciences during the 3rd quarter valued at approximately $297,000. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.